Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

36.23
Delayed Data
As of May 20
 +1.08 / +3.07%
Today’s Change
27.87
Today|||52-Week Range
93.66
-45.35%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Anzalone Christopher Richard
Chief Executive Officer
Sale2/11/202261,482$50.90$3.1M-28.51%
Anzalone Christopher Richard
Chief Executive Officer
Sale10/22/202144,170$65.57$2.9M-45.16%
Anzalone Christopher Richard
Chief Executive Officer
Sale2/11/202242,153$52.28$2.2M-28.51%
Anzalone Christopher Richard
Chief Executive Officer
Sale2/11/202240,853$53.11$2.2M-28.51%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/15/202125,857$66.28$1.7M-48.53%
Anzalone Christopher Richard
Chief Executive Officer
Sale12/15/202114,857$67.19$998.2K-48.53%
Anzalone Christopher Richard
Chief Executive Officer
Sale10/20/202115,000$66.23$993.5K-45.75%
San Martin Javier
Chief Medical Officer
Sale11/19/202113,704$69.01$945.7K-49.08%
Anzalone Christopher Richard
Chief Executive Officer
Buy2/11/2022146,388$5.19$759.8K-28.51%
Obrien Patrick /arrowhead/
General Counsel
Sale1/05/202212,434$60.49$752.1K-39.83%
Page of 6